An integrated understanding of the metabolic benefits of a novel double-targeted genetically engineered probiotic expressing aldafermin intervention with dietary change on NAFLD
Babu, A.F., Iannone, V., Lok, J., Gomez-Gallego, C., D'Auria, G., Vazquez-Uribe, R., Pihlajamaki, J., Sommer, M., Hanhineva, K., El-Nezami, H., Kohlemainen, M.
Published in Atherosclerosis (01.08.2023)
Published in Atherosclerosis (01.08.2023)
Get full text
Journal Article